↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

195 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   ABX-464  0件:   -   -   -   3件:
46,
96,
97
 2   ATL-2502  1件: Atl-2502;   -   -   -   1件:
97
 3   Abatacept  27件: Abatacept; Abatacept injection; Bms 188667 (abatacept); Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept (bms-188667); Abatacept (iv); Abatacept + csdmard; Abatacept + methotrexate; Abatacept + vaccines; Abatacept placebo; Abatacept prefilled syringe; Abatacept, rituximab or tocilizumab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Decrease tocilizumab, abatacept; Double-blind abatacept; Intravenous (iv) abatacept; Iv abatacept; Open-label abatacept; Orencia (abatacept); Orencia abatacept; Subcutaneous (sc) abatacept; Subcutaneous abatacept; Subcutaneous(sc) abatacept; Tocilizumab, abatacept; Abatacept subcutaneous; Abatacept sc; Abatacept (aba);   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300
 4   Acetate  81件: Acetate; Leuprorelin acetate; 40 mg glatiramer acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Flecainide acetate; Oxaloacetate (oaa); Ulipristal acetate; 11c-acetate; 20mg/0.5ml glatiramer acetate; Bazedoxifene acetate; Cyclophosphamide/glatiramer acetate; Dirucotide acetate; Experimental glatiramer acetate; Glatiramer acetate; Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Human interferon beta-1a and glatiramer acetate; Nomegestrol acetate; Plovamer acetate; Prednisone acetate; Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Tocopherol acetate; Depot leuprolide acetate 3.75 mg; Caspofungin acetate; Desmopressin acetate; Lanreotide acetate; Abiraterone acetate; Gonadorelin acetate and triptorelin acetate; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate 3.75mg injection; Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Megestrol acetate; Megestrol acetate tablet; Triptorelin acetate and gonadorelin acetate; Macimorelin acetate; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Hydrocortisone sodium acetate; Sodium acetate; Tetracosactide acetate; 11c acetate; Dichloroacetate; Dichloroacetate sodium; Zuretinol acetate; Etiprednol dicloacetate; Delmitide acetate; L-lysyl-d-prolyl-l-threonine acetate; Sotrastaurin (inn) acetate; Cosyntropin acetate; Tetracosactide hexaacetate; Glatiramer acetate (copaxone®); Zinc acetate; Zinc acetate dihydrate; Tocopheryl acetate; Prednisolone acetate; Prednisone acetate tablets; Desmopressin acetate trihydrate; Phosphate and betamethasone acetate, 2 ml.; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; Loestrin (norethindrone acetate and ethinyl estradiol); Zinc acetate (20mg/d);   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299
 5   Acetic acid  1件: Acetic acid;   D00010   -   -   1件:
97
 6   Acetylcysteine  8件: Acetylcysteine; N-acetylcysteine; N-acetylcysteine capsule; Glatiramer acetate, n-acetylcysteine; N acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine, (nac); Acetylcysteine sodium;   D00221   -   -   16件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
96,
97,
111,
164,
233,
298,
299
 7   Activated charcoal  0件:   D03251   -   -   8件:
6,
13,
46,
85,
86,
96,
97,
298
 8   Adalimumab  51件: Adalimumab; Adalimumab injection [humira]; Adalimumab (ada); Adalimumab (humira); Adalimumab (humira®); Adalimumab (up to 9 months exposure); Adalimumab 40 mg; Adalimumab 40 mg subcutaneous (sc) every other week (eow); Adalimumab 40mg q2w; Adalimumab 80 mg; Adalimumab pfs and pen; Adalimumab with methotrexate; Adalimumab-eu; Adalimumab-pfizer; Anti-tnf therapy (etanercept or adalimumab); Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Biosimilar product to adalimumab; Double-blind adalimumab; Etanercept or adalimumab; Humira (adalimumab); Humira 40mg solution for injection in pre-filled syringe (adalimumab); Humira® (adalimumab); Infliximab, etanercept, adalimumab; Methotrexate,adalimumab; New formulation adalimumab; Open-label adalimumab; Open-labeladalimumabrescue; Sb5 (proposed biosimilar to adalimumab); Tnf blockers (infliximab, adalimumab, etanercept); Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Adalimumab (40 mg); Adalimumab (d2e7); Adalimumab 40 mg eow or ew; Adalimumab and infliximab; Adalimumab injection; Adalimumab prn; Anti-tnf:adalimumab (subcutaneus); Application of adalimumab; Azathioprine or adalimumab and infliximab; Db adalimumab 40 mg eow; Db adalimumab 40 mg ew; Fitc-adalimumab; Infliximab and adalimumab; Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Infliximab, adalimumab, certolizumab pegol; Ol adalimumab 40 mg; Start adalimumab in monotherapy; Treatment with adalimumab; Adalimumab 40 mg sc every other week; Adalimumab, etanercept, golimumab or infliximab; Gp2017 (adalimumab biosimilar);   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271
 9   Ademetionine  0件:   D07128   -   -   15件:
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172
 10   Aldesleukin  3件: Aldesleukin; Low-dose aldesleukin (proleukin®); Interleukin-2 (aldesleukin).;   D00748   3件: IL2RA, IL2RB, IL2RG   3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Pathways in cancer   4件:
2,
49,
65,
97
 11   Alicaforsen  1件: Alicaforsen;   -   -   -   2件:
96,
97
 12   Alkaline Phosphatase  6件: Alkaline phosphatase; Bovine intesastinal alkaline phosphatase (biap); Bovine intestinal alkaline phosphatase (biap); Bovine-calf alkaline phosphatase (biap); Bovine-calf alkaline phosphatase biap; Human recombinant tissue non-specific alkaline phosphatase fusion protein;   -   -   -   3件:
46,
97,
172
 13   Allopurinol  4件: Allopurinol; Allopurinol sandoz 100 mg, tabletten; Allopurinol sodium; Azathioprine and allopurinol;   D00224   1件: XDH   2件: Peroxisome, Purine metabolism   6件:
6,
46,
57,
66,
96,
97
 14   Aloe Vera Leaf  0件:   -   -   -   1件:
97
 15   Aminosalicylic Acid  8件: -aminosalicylic acid; 4-aminosalicylic acid; 4-aminosalicylic acid extended release granules; 5-aminosalicylic acid; Aminosalicylic acid; Mesalamine, 5-aminosalicylic acid; 5-aminosalicylic acid (5-asa); 5-aminosalicylic acid(5-asa) and/or prednisone;   D00162   -   -   2件:
96,
97
 16   Amoxicillin  7件: Amoxicillin; Clartihromycin, amoxicillin, and omeprazole; Amoxicillin hydrate; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); Amoxicillin and tetracycline; Amoxicillin, metronidazole and tetracycline; Lansoprazole, amoxicillin, clarithromycin;   D00229
 D02925
 D07452 
 -   -   6件:
6,
46,
63,
96,
97,
222
 17   Andrographolide  5件: And (andrographolide); Andrographolide; Dand (14-deoxyandrographolide); Ddand (14-deoxy-11,12-didehydroandrographolide); Nand (neoandrographolide);   -   -   -   1件:
97
 18   Anrukinzumab  1件: Anrukinzumab;   D08857   -   -   1件:
97
 19   Apigenin  2件: Aodg (apigenin-7-o-glucuronide); Apigenin;   -   -   -   1件:
97
 20   Apixaban  2件: Apixaban; Apixaban 2.5 milligram;   D03213   1件: F10   1件: Complement and coagulation cascades   2件:
96,
97
 21   Apremilast  7件: Apremilast; Apremilast 20 mg; Apremilast 30 mg; Apremilast 30mg; Apremilast (cc-10004); Apremilast tablet 20 mg; Apremilast tablet 30 mg bid;   D08860   4件: PDE4A, PDE4B, PDE4C, PDE4D   2件: Purine metabolism, cAMP signaling pathway   5件:
46,
50,
56,
97,
271
 22   Ascorbic acid  4件: Ascorbic acid; Ascorbic acid (vitamin c); Ascorbic acid vit c; 2l polyethylene glycol/ascorbic acid;   D00018   -   -   13件:
10,
13,
49,
62,
86,
96,
97,
192,
206,
211,
212,
254,
284
 23   Aspergillus oryzae  1件: Aspergillus oryzae;   -   -   -   1件:
97
 24   Azathioprine  33件: Azathioprine; Prednisone - azathioprine; Azathioprine (aza); Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Corticosteroid and azathioprine; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Azathioprine 25 mg; Continuation of azathioprine; Cyclophosphamide-prednisone-azathioprine; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Rituximab (rtx) and azathioprine (aza); Steroids plus azathioprine; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; Azathioprine (aza) or 6-mercaptopurine (6-mp); Azathioprine in case of endoscopic recurrence; Azathioprine individualised dose; Azathioprine or 6-mercaptopurine; Azathioprine or adalimumab and infliximab; Azathioprine or mesalazine; Azathioprine or methotrexate; Azathioprine weight-based dose; Azathioprine+enteral nutrition; Early immunosuppressants (azathioprine, methotrexate); Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, azathioprine; Azathioprine and allopurinol; Overencapsulated azathioprine (imuran) 50 mg tablet; Products containing azathioprine or 6-mercaptopurine; Azathioprine or mycophenolate mofetil;   D00238
 D03033 
 -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162
 25   Balsalazide  2件: Balsalazide; Balsalazide disodium;   D02715
 D07488 
 -   -   1件:
97
 26   Baminercept  3件: Baminercept; Baminercept alfa; Baminercept alfa (bg9924);   D08866   1件: LTB   3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
53,
97
 27   Basiliximab  1件: Basiliximab;   D03058   1件: IL2RA   4件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, JAK-STAT signaling pathway   7件:
2,
50,
65,
66,
97,
222,
228
 28   Beclomethasone dipropionate  1件: Beclomethasone dipropionate;   D00689
 D07495 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
97,
98
 29   Berberine  2件: Berberine; Berberine chloride;   D00092   -   -   1件:
97
 30   Bifidobacterium longum infantis  0件:   -   -   -   2件:
96,
97
 31   Bimekizumab  1件: Bimekizumab;   D11550   2件: IL17A, IL17F   2件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway   3件:
46,
97,
271
 32   Budesonide  39件: Budesonide; Budesonide ( zentacort capsules 3mg ); Methylprednisolone or budesonide; Budesonide (6 mg); Budesonide (9 mg); Budesonide 6 mg capsules, hard (bux-pvii prototype); Budesonide 9 mg capsules, hard (bux-pv); Budesonide 9 mg capsules, hard (bux-pvii prototype); Budesonide mmx 6 mg tablet; Budesonide mmx®; Budesonide mmx® 6 mg; Budesonide mmx® 9 mg; Budesonide-mmx; Budesonide-mmx®; Budesonide-mmx® 6 mg; Budesonide-mmx® 9 mg; Budesonide-mmx™; Combination oral budesonide and rectal hydrocortisone; 0.5 mg budesonide effervescent tablet for orodispersible use; 1 mg budesonide effervescent tablet for orodispersible use; 1mg budesonide effervescent tablet for orodispersible use; 2mg budesonide effervescent tablet for orodispersible use; Budesonide 0.5mg orodispersible tablet twice daily; Budesonide 1mg orodispersible tablet twice daily; Budesonide [0.4mg/ml] viscous suspension; Budesonide oral suspension; Budesonide oral suspension [0.2 mg/ml]; Budesonide plus prevacid; Inhaled/swallowed budesonide; Oral budesonide; Oral budesonide suspension (mb-9); Oral budesonide suspension (obs); Oral viscous budesonide; Oral viscous budesonide (ovb); Viscous/swallowed budesonide; Budesonide/formoterol; Formoterol/budesonide; Budesonide-formoterol single inhaler; High dose of budesonide;   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   10件:
66,
85,
93,
94,
95,
96,
97,
98,
228,
299
 33   Butyric Acid  0件:   D05866   -   -   5件:
34,
51,
56,
97,
291
 34   Caffeine  5件: Caffeine; Caffeine 100-200 mg bid; Caffeine alkaloid; Dextromethorphan and caffeine; Caffeine 100 mg;   D00528
 D01453 
 9件: ADORA1, ADORA2A, PDE1B, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cAMP signaling pathway   6件:
2,
6,
46,
78,
96,
97
 35   Calcium  26件: Calcium; Calcium carbonate; Calcium levofolinate; Ascal(r) / carbasalate calcium; Calcium and cholecalciferol; Calcium citrate; Carbasalate calcium; Ethylhydrogenfumarat, calciumsalz; Ibandronate+alfacalcidol+calcium; Rosuvastatin calcium; Calcium channel blockers; Calcium channel blockers (amlodipine, azelnidipine); Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Calcium citrate with vitamin d2; Vidofludimus calcium; Calcium gluconate; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); Low molecular weight heparin calcium injection; Amorphous calcium carbonate; Calcitriol & calcium; Calcium carbonate and alphacalcidol; Calcium lactate; Crystalline calcium supplements; Atorvastatin calcium; Calcium, dietary;   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299
 36   Cannabidiol  6件: Cannabidiol; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol capsule 5 mg; Cannabidiol tablet 10 mg; Cannabidiol (cbd); Cannabidiol oral solution;   D10915   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   14件:
2,
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271
 37   Carbon dioxide  1件: Carbon dioxide;   D00004   -   -   1件:
97
 38   Casein  2件: Casein; Casein glycomacropeptide (cgmp);   -   -   -   1件:
97
 39   Catridecacog  1件: Catridecacog;   D10532   -   -   2件:
97,
288
 40   Ceftriaxone  1件: Ceftriaxone;   D00924
 D07659 
 -   -   3件:
2,
6,
97
 41   Cefuroxime  1件: Cefuroxime;   D00262
 D00914
 D00915
 D03431 
 -   -   1件:
97
 42   Certolizumab pegol  11件: Certolizumab pegol; 99mtc-s-hynic certolizumab pegol; Certolizumab pegol (cdp870, tradename cimzia); Certolizumab pegol (cdp870, tradename cimzia)(prefilled syringes at the dose of 200mg); Certolizumab pegol (czp); Certolizumab pegol + methotrexate (mtx); Certolizumab pegol (cdp870); Certolizumab pegol (rinn); Certolizumab pegol 400 mg; Infliximab, adalimumab, certolizumab pegol; Cimzia certolizumab pegol 200 mg/ml solution for injection;   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   6件:
37,
46,
96,
97,
226,
271
 43   Chamomile  0件:   D09212   -   -   1件:
97
 44   Chloride ion  0件:   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299
 45   Chlorogenic Acid  2件: Chlorogenic acid; Cla (chlorogenic acid);   -   -   -   1件:
97
 46   Cholecalciferol  9件: Cholecalciferol; Cholecalciferol, vitamin d3; Calcium and cholecalciferol; Cholecalciferol and c. xanthorrhiza; Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol concentrate; 5000 iu of cholecalciferol; Cholecalciferol (vitamin d3);   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   15件:
6,
13,
19,
20,
34,
46,
49,
53,
60,
65,
96,
97,
228,
298,
299
 47   Ciclosporin  7件: Ciclosporin; Ciclosporina; Ciclosporine; Aerolised liposomal ciclosporin a; Ciclosporin (ciclosporinium); Ciclosporin a; Ciclosporine, ciclosporina;   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   44件:
11,
14,
19,
20,
26,
28,
36,
38,
39,
40,
41,
42,
45,
46,
49,
50,
53,
55,
56,
58,
60,
61,
62,
63,
64,
65,
90,
95,
97,
113,
162,
164,
222,
223,
226,
228,
234,
269,
274,
283,
284,
285,
302,
326
 48   Ciprofloxacin  14件: Ciprofloxacin; Fixed dose combination ciprofloxacin/celecoxib; Ciprofloxacin hydrochloride; Cipro (ciprofloxacin, bayq3939); Ciprofloxacin (cipro inhale, bayq3939); Ciprofloxacin (cipro, bayq3939); Ciprofloxacin (ciproxin); Ciprofloxacin dispersion for inhalation; Ciprofloxacin dpi; Ciprofloxacin for inhalation; Ciprofloxacin hydrochloride monohydrate; Oral ciprofloxacin; Oral ciprofloxacin plus inhaled colistin; Po ciprofloxacin;   D00186
 D02216 
 -   -   5件:
2,
60,
96,
97,
299
 49   Clarithromycin  6件: Clarithromycin; Lansoprazole, clarithromycin, amoxycillin; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); Rifabutin, clarithromycin, and clofazimine; Lansoprazole, amoxicillin, clarithromycin; Biaxin ( clarithromycin);   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299
 50   Clotrimazole  1件: Clotrimazole;   D00282   -   -   1件:
97
 51   Cobitolimod  1件: Cobitolimod;   -   -   -   1件:
97
 52   Curcumin  6件: Curcumin; Ifn beta 1 a + curcumin (bcm 95); Nanocurcumin; Curcumin (longvida™); Curcumin supplement; Bio-enhanced curcumin soft gelatin capsule;   -   -   -   10件:
13,
46,
49,
67,
74,
94,
96,
97,
139,
299
 53   Cyanocobalamin  0件:   D00166
 D03615
 D03616
 D03617 
 -   -   12件:
6,
13,
49,
62,
86,
96,
97,
201,
229,
254,
284,
299
 54   Cyclic GMP  0件:   -   -   -   1件:
97
 55   D-Proline  2件: D-proline; Lysine-d-proline-threonine;   -   -   -   1件:
97
 56   Daclizumab  7件: Biib019 (daclizumab); Daclizumab; Daclizumab (anti-cd25 humanized monoclonal antibody); Daclizumab high yield process; Daclizumab hyp; Daclizumab hyp (dac hyp); Daclizumab with greek suufix;   D03639   1件: IL2RA   4件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, JAK-STAT signaling pathway   7件:
13,
56,
60,
65,
97,
283,
284
 57   Dersalazine  2件: Dersalazine; Dersalazine sodium;   -   -   -   1件:
97
 58   Dexamethasone  35件: Dexamethasone; Dexamethasone soduim phosphate; Lenalidomide and dexamethasone; Lenalidomide+dexamethasone; Lenalidomide, dexamethasone; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Dexamethasone, 40 mg; Lenalidomide, dexamethasone and cyclophosphamide; Melphalan, thalidomide and dexamethasone; Pomalidomide and dexamethasone; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Dexamethasone (50mg 1dd6, 3 consecutive days/month); Control intervention (no dexamethasone); Intraarticular dexamethasone; Intravenous dexamethasone 1 mg; Peri-neural dexamethasone 1 mg; Dexamethasone parotid irrigation; Dexamethasone (1 cycle); Dexamethasone (4 cycles); Dexamethasone abcur; Dexamethasone and rituximab; High dose dexamethasone pulses; Dexamethasone sodium phosphate; Dexamethasone sodium phosphate ph. eur.; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Dexamethasone 0.5mg tablet; Dexamethasone 2mg tablets; Dexamethasone 0,5mg; Bupivacaine/epinephrine/dexamethasone; Dexamethasone sodium phosphate 250 mg/ 10 ml; Dexamethasone 21-phosphate; Mmf and dexamethasone; Dexamethasone sodium phosphate 250 mg/10 ml solution;   D00292
 D00975
 D01510
 D01615
 D01632
 D01948
 D02174
 D02591
 D02592 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299
 59   Dextran  4件: Dextran; Dextran sulfate sodium; Iron dextran; Iron(iii)- hydroxide dextran complex;   D00060   -   -   5件:
2,
62,
79,
96,
97
 60   Dextromethorphan  9件: Dextromethorphan; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; Dextromethorphan hydrobromide; Dextromethorphan and caffeine; Dextromethorphan 30 mg;   D00848
 D03742
 D03744 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   2件: Glutamatergic synapse, Neuroactive ligand-receptor interaction   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156
 61   Docusate  0件:   D00305   -   -   7件:
13,
62,
86,
96,
97,
254,
284
 62   Doxycycline  7件: Doxycycline; Interferon beta 1a, oral doxycycline; Doxycycline hyclate; Antimicrobial therapy: co-trimoxazole or doxycycline; Doxycycline 100 mg capsules; Treatment with systemic therapy (doxycycline); Doxycycline hyclate ph.eur;   D00307
 D02129
 D03903
 D03904
 D07876 
 -   -   15件:
13,
23,
28,
46,
84,
85,
89,
96,
97,
158,
162,
167,
227,
280,
299
 63   Entecavir  1件: Entecavir;   D04008
 D07896 
 -   -   5件:
46,
56,
96,
97,
271
 64   Ergocalciferol  2件: Ergocalciferol; Ergocalciferol (vitamin d2);   D00187   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   5件:
46,
84,
96,
97,
299
 65   Ethanol  14件: Endocannabinoid palmitoylethanolamide (pea); Palmitoylethanolamide; Treprostinil diethanolamine; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate;   D00068
 D02798
 D04855
 D06542 
 -   -   49件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
58,
61,
63,
64,
65,
66,
81,
84,
85,
86,
88,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
279,
280,
283,
284,
285,
288,
298,
299,
300,
331
 66   Etrasimod  1件: Etrasimod;   D10930   5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5   2件: Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
97
 67   Etrolizumab  1件: Etrolizumab;   D09901   1件: ITGB7   1件: Intestinal immune network for IgA production   2件:
96,
97
 68   Ferric carboxymaltose  2件: Ferric carboxymaltose; Intravenous administration of ferric carboxymaltose;   D08920   -   -   4件:
86,
96,
97,
299
 69   Filgotinib  4件: Filgotinib; Inn - filgotinib; Proposed inn - filgotinib; Propsoed inn - filgotinib;   D10871   1件: JAK1   3件: JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   6件:
46,
53,
96,
97,
222,
271
 70   Fluorescein  1件: Fluorescein;   D01261
 D02024 
 -   -   3件:
19,
97,
215
 71   Flupentixol  1件: Flupentixol;   D01044   2件: DRD1, DRD2   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   1件:
97
 72   Folic acid  5件: Folic acid; Folic acid, vitamin b6, vitamin b12; Folic acid or folate; Rituximab, mtx, folic acid; Methotrexate and folic acid;   D00070   -   -   11件:
6,
13,
46,
49,
62,
84,
86,
96,
97,
254,
284
 73   Fosfomycin  1件: Fosfomycin;   D00925
 D02187
 D02188
 D04253 
 -   -   2件:
96,
97
 74   GLPG-0974  0件:   -   -   -   1件:
97
 75   GLPG-1205  0件:   -   -   -   3件:
85,
96,
97
 76   GS-5745  3件: Gs-5745; Gs-5745 iv; Gs-5745 sc;   -   -   -   2件:
46,
97
 77   Gabapentin  7件: Gabapentin; Gabapentina; Gabapentina kern pharma; Gabapentine; Gabapentine 300mg; Transdermal fentanyl matrix, gabapentin; Gabapentin prescriptions;   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   2件: GABAergic synapse, MAPK signaling pathway   7件:
6,
13,
19,
70,
97,
226,
298
 78   Ganciclovir  2件: Ganciclovir; Valganciclovir;   D00333
 D04301 
 -   -   3件:
28,
60,
97
 79   Gelatin  3件: Gelatin; Bio-enhanced curcumin soft gelatin capsule; Neoral soft gelatin capsules;   D00115
 D06892 
 -   -   4件:
47,
78,
97,
269
 80   Glycyrrhiza glabra  2件: Glycyrrhiza glabra; Glycyrrhiza glabra root;   -   -   -   1件:
97
 81   Golimumab  36件: Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Golimumab; Golimumab 100 mg; Golimumab 100 mg injections; Golimumab 2 mg/kg iv; Golimumab 50 mg; Golimumab 50 mg injections; Golimumab final vialed product (fvp); Golimumab intravenous; Golimumab intravenous (iv); Golimumab liquid in prefilled pen; Golimumab liquid in prefilled syringe; Golimumab liquid in vial; Golimumab pre-filled syringe; Iv golimumab; Sc golimumab; Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Exposure to golimumab; Golimumab (glm); Golimumab (optimization); Golimumab 1 mg per kg; Golimumab 2 mg per kg; Golimumab 200 mg; Golimumab 4 mg per kg; Golimumab 400 mg; Golimumab 50 mg in patients <80 kg and golimumab 100 mg in patients >80 kg; Golimumab dose 1; Golimumab dose 2; Golimumab prefilled syringe; Golimumab treatment optimization.; Simponi (golimumab); Simponi® (golimumab); Adalimumab, etanercept, golimumab or infliximab; Golimumab (cnto 148); Golimumab injection;   D04358   1件: TNF   9件: Adipocytokine signaling pathway, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   5件:
46,
84,
96,
97,
271
 82   Grapefruit  2件: Grapefruit; Grapefruit juice;   -   -   -   5件:
6,
46,
50,
83,
97
 83   Guaiazulen  1件: Guaiazulene;   -   -   -   1件:
97
 84   Guselkumab  4件: Guselkumab; Guselkumab 100 mg; Guselkumab dose 1; Guselkumab dose 2;   D10438   1件: IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   3件:
37,
96,
97
 85   HE3286  1件: He3286;   -   -   -   2件:
46,
97
 86   Hepatitis A Vaccine  3件: Hepatitis a vaccine; Hepatitis a vaccine and tetanus vaccine; Epaxal berna (virosomal hepatitis a vaccine);   -   -   -   3件:
46,
96,
97
 87   Human interferon beta  6件: Human interferon beta; Human interferon beta 1a (rebif); Human interferon beta-1a and glatiramer acetate; New formulation of rebif - human interferon beta-1a; Recombinant human interferon beta; Recombinant human interferon beta-1a;   -   -   -   6件:
13,
14,
20,
26,
96,
97
 88   Human interleukin-2  3件: Human interleukin-2; Recombinant human interleukin-2 (rhil-2); Anti-human interleukin-23 monoclonal antibody;   -   -   -   14件:
2,
13,
35,
46,
49,
51,
55,
56,
63,
65,
95,
96,
97,
271
 89   Hyaluronic acid  5件: Hyaluronic acid; Standard care hyaluronic acid eye drops; Hyaluronic acid and chondroitin sulfate; Hyaluronic acid/chondroitin sulfate; Hyaluronic acid inhalation solution;   D08043   -   -   7件:
46,
53,
70,
97,
226,
231,
299
 90   Hydrocortisone  22件: Hydrocortisone; Hydrocortisone cream; Hydrocortisone cream 1%; Hydrocortisone cream 10mg/g fna fagron; Subcutaneous hydrocortisone 10mg; Hydrocortisone sodium phosphate; Hydrocortisone takeda, tabletter; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Dual release hydrocortisone (plenadren); Hydrocortisone (solucortef); Hydrocortisone 10mg tablet; Hydrocortisone 20mg tablets; Hydrocortisone modified release capsules; Hydrocortisone sodium acetate; Subcutaneous hydrocortisone; Cortef (hydrocortisone); Hydrocortisone efcortesol & solu-cortef; Hydrocortisone roussel; Solu-cortef (hydrocortisone); Combination oral budesonide and rectal hydrocortisone; Hydrocortisone sodium succinate; Mesalazine with hydrocortisone sodium succinate;   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
6,
53,
75,
78,
81,
83,
97,
299
 91   Hydrocortisone acetate  0件:   D00165   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
6,
53,
75,
78,
81,
83,
97,
299
 92   Hydrogen  4件: Hydrogen; 3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate; Lisuride hydrogenmaleate; Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt);   -   -   -   5件:
5,
6,
17,
97,
226
 93   Hydroxide ion  0件:   -   -   -   4件:
46,
96,
97,
284
 94   Hydroxyethyl Starch  0件:   D03335   -   -   2件:
96,
97
 95   Icosapent  1件: Eicosapentaenoic acid;   D08061   -   -   5件:
49,
96,
97,
296,
297
 96   Infliximab  66件: Infliximab; Infliximab [infliximab biosimilar 3]; Topical infliximab; Remicaide (infliximab); Abp 710 - biosimilar to infliximab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Biosimilar infliximab; Infliximab (inf) + mtx, db; Infliximab (remicade); Infliximab + methotrexate (mtx); Infliximab 10 mg/kg; Infliximab 3 mg/kg; Infliximab biosimilar; Infliximab control; Infliximab group; Infliximab increased dose; Infliximab increased frequency; Infliximab, etanercept; Infliximab, etanercept, adalimumab; Infliximab, methylprednisolone, methotrexate; Infliximab-eu; Infliximab-pfizer; Innovator infliximab; Methotrexate + infliximab; Remicade (infliximab); Remicade® (infliximab); Remsima (infliximab); Response to infliximab associated with methotrexate; Sb2 (infliximab biosimilar); Sb2 (proposed biosimilar to infliximab); Ta-650 (infliximab); Tnf blockers (infliximab, adalimumab, etanercept); Trexan+salazopyrin+oxiklorin+prednisolone + infliximab; Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Intravitreal infliximab; 99m technetium infliximab; 99mtc-infliximab; Inflectra (infliximab); Adalimumab and infliximab; Anti tnf therapy including infliximab; Anti-tnf: infliximab (infusion); Azathioprine or adalimumab and infliximab; Ct-p13 sc (infliximab); Infliximab (ifx alone); Infliximab (remicade): 100 mg of lyophilized infliximab; Infliximab 20 mg/kg; Infliximab 5 mg/kg; Infliximab 5 mg/kg body weight infused over 2 hours; Infliximab 5 mg/kg every 6 weeks; Infliximab 7 mg/kg every 8 weeks; Infliximab and adalimumab; Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab infusion; Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, adalimumab, certolizumab pegol; Infliximab, azathioprine; Infliximab-biosimilar; Infliximab-innovator; Cyclosporine vs infliximab; Infliximab (ifx); Adalimumab, etanercept, golimumab or infliximab; Infliximab (bcd-055); Infliximab and mtx;   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   23件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
85,
95,
96,
97,
98,
162,
164,
269,
271
 97   Inositol  1件: Inositol;   D08079   -   -   2件:
96,
97
 98   Interferon beta-1a  24件: Avonex (interferon beta-1a), biogen idec ltd; Bg9418 (interferon beta-1a); Biib017 (peginterferon beta-1a); Human interferon beta-1a and glatiramer acetate; Interferon beta-1a; Interferon beta-1a (avonex); Interferon beta-1a (avonex®); Interferon beta-1a (current approved manufacturing process invloving fbs); Interferon beta-1a (new process, manufactured without fbs); Interferon beta-1a (rebif); Interferon beta-1a 30 µg; Interferon beta-1a fbs-free/hsa-free, rnf; Interferon beta-1a hsa+ biosimilar; Interferon beta-1a hsa-free biosimilar; Interferon beta-1a original; New formulation of rebif - human interferon beta-1a; Peginterferon beta-1a; Pegylated interferon beta-1a; Plegridy (peginterferon beta-1a), biogen idec ltd; Rebif (interferon beta-1a); Rebif (interferon beta-1a), merck serono europe ltd; Sc interferon beta-1a; Sc peginterferon beta-1a; Recombinant human interferon beta-1a;   D04554   2件: IFNAR1, IFNAR2   4件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Toll-like receptor signaling pathway   5件:
13,
14,
26,
96,
97
 99   Iron  18件: Iron; Iron oxide; Ultra small particles of iron oxide (uspio); Ultrasmall particles of iron oxide; Iron dextran; Iron sucrose; Ambrisentan plus spironolactone; Iron supplement; Spironolactone; Spironolactone and conivaptan; Spironolactone captopril carvedilol; Injection of iron; Iron sulphate; Iron sulphate 200mg coated tablets; Iron supplement 300-600 mg/day; Iron(iii)- hydroxide dextran complex; Oral iron; Iron chelating agents;   -   -   -   7件:
13,
62,
86,
96,
97,
254,
284
 100   Iron saccharate  0件:   -   -   -   3件:
62,
96,
97
 101   Isopropyl alcohol  0件:   D00137   -   -   10件:
13,
46,
58,
84,
96,
97,
269,
271,
279,
298
 102   Itacitinib  1件: Itacitinib;   D10944   1件: JAK1   2件: JAK-STAT signaling pathway, PI3K-Akt signaling pathway   4件:
46,
60,
97,
228
 103   L-Glutamine  1件: L-glutamine;   D00015   -   -   6件:
87,
96,
97,
113,
245,
299
 104   L-Lysine  2件: L-lysine; L-lysine-n-acetylcysteinate;   D02304   -   -   4件:
13,
97,
228,
299
 105   L-Threonine  2件: L-lysyl-d-prolyl-l-threonine acetate; L-threonine;   D00041   -   -   3件:
86,
96,
97
 106   Lactobacillus reuteri  1件: Lactobacillus reuteri;   -   -   -   2件:
97,
299
 107   Lactose  4件: Lactose; Lactose monohydrate; 2'-fucosyllactose; Lactose in water;   D00046
 D03226 
 -   -   6件:
2,
6,
13,
97,
228,
310
 108   Levocarnitine  4件: Levocarnitine; Valproate, levocarnitine; Valproic acid and levocarnitine; Levocarnitine propyl hydrochloride;   D02030
 D02176
 D04713 
 -   -   10件:
3,
5,
13,
53,
58,
96,
97,
265,
298,
316
 109   Lidocaine  8件: Lidocaine; Local anesthesia (lidocaine hydrochloride); Lidocaine patch 5%; Lidocaine injection 2%; 5% lidocaine/5 mg/ml estradiol compound cream; Alkalinized lidocaine-heparin; Bladder instillation with heparin/ lidocaine; Lidocaine releasing intravesical system - liris®;   D00358
 D02086
 D08127 
 2件: SCN1A, SCN5A   2件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse   10件:
6,
13,
46,
84,
86,
97,
168,
226,
231,
256
 110   Linaclotide  1件: Linaclotide;   D09355   -   -   1件:
97
 111   Loperamide  1件: Loperamide;   D00729
 D07113
 D08144 
 3件: OPRD1, OPRK1, OPRM1   1件: Neuroactive ligand-receptor interaction   2件:
13,
97
 112   Losartan  8件: Losartan; Losartan bluefish 50 mg; Sildenafil and losartan; Losartan potassium; Losartan and atenolol or propranolol; Losartan potasico; Lisinopril, losartan, and atorvastatin; Losartan tablets & qingremoshen granule;   D00357
 D08146 
 1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   18件:
13,
17,
19,
46,
58,
66,
67,
85,
96,
97,
98,
113,
164,
167,
179,
215,
222,
299
 113   Magnesium  16件: Magnesium; Magnesium oxide; Magnesium sulfate; Mineral boost (magnesium); Sulfate, magnesium; Saroglitazar magnesium 2 mg; Saroglitazar magnesium 4 mg; Magnesium citrate; Sodium picosulfate/magnesium citrate laxative; Omeprazole magnesium; (s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; (s)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; Magnesium hydroxide; Sodium picosulfate, magnesium oxide and citric acid; Magnesium gluconate; Nexium (esomeprazole magnesium);   -   -   -   15件:
6,
11,
13,
46,
64,
93,
97,
166,
225,
235,
284,
291,
296,
297,
298
 114   Magnesium citrate  2件: Magnesium citrate; Sodium picosulfate/magnesium citrate laxative;   D03265   -   -   1件:
97
 115   Maltodextrin  3件: Maltodextrin; Resistant maltodextrin; Maltodextrin fiber supplement;   D02329   -   -   4件:
6,
13,
96,
97
 116   Maltose  3件: Ferric carboxy maltose; Ferric carboxymaltose; Maltose;   D00044   -   -   2件:
96,
97
 117   Medical Cannabis  0件:   -   -   -   6件:
2,
6,
13,
90,
96,
97
 118   Melatonin  10件: Melatonin; Melatonin pr; Melatonin(circadin®); 3 mg melatonin; 5 mg melatonin; Circadin ( inn= melatonin); Diazepam, melatonin; Dtr melatonin (nih cc pds); Hourly dosing of the nychtemeral secretion of melatonin; Melatonin cr;   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   8件:
6,
13,
46,
49,
90,
97,
144,
202
 119   Melitracen  1件: Melitracen;   D08171   -   -   1件:
97
 120   Mercaptopurine  8件: 6 mercaptopurine; Azathioprine (aza) or 6-mercaptopurine (6-mp); Azathioprine or 6-mercaptopurine; Delayed release 6 mercaptopurine; Mercaptopurine; 6-mercaptopurine; Mercaptopurine (puri-nethol); Products containing azathioprine or 6-mercaptopurine;   D00161
 D04931 
 1件: HPRT1   1件: Purine metabolism   5件:
86,
94,
96,
97,
164
 121   Mesalazine  27件: Mesalazine; Azathioprine or mesalazine; Mesalazine (mesalamine); Mesalazine ec 500 mg; Mesalazine sustained-release tablets; Mesalazine tablets; Mesalazine, tripterygium glycosides; 1500mg mesalazine pellets; 250mg mesalazine pellets; 500mg mesalazine pellets; 750mg mesalazine pellets; Mesalazine (3,600 mg); Mesalazine - tid 1000 mg; Mesalazine - tid 2x 500 mg; Mesalazine 1000 mg gastro-resistant tablets; Mesalazine 250mg; Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet; Mesalazine 4g enema; Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg); Mesalazine enema; Mesalazine tablet; Mesalazine with hydrocortisone sodium succinate; Mmx mesalamine/mesalazine; Mmx mesalamine/mesalazine (high dose); Mmx mesalamine/mesalazine (low dose); Overencapsulated mesalazine tablets; Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine;   D00377   -   -   4件:
46,
96,
97,
164
 122   Methotrexate  81件: Methotrexate; Intrathecal methotrexate; Methotrexate treatment; Mycophenolate mofetil,methotrexate; Methotrexate 2.5 mg; Methotrexate 25 mg; Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept + methotrexate; Adalimumab with methotrexate; Bms-582949 and methotrexate; Certolizumab pegol + methotrexate (mtx); Cp-690,550 + methotrexate; Etanercept + methotrexate; Etanercept , methotrexate; Infliximab + methotrexate (mtx); Infliximab, methylprednisolone, methotrexate; Methotrexate 'lederle' 2,5mg tablets; Methotrexate 'lederle' 2.5mg tablets; Methotrexate (metoject® prefilled pen); Methotrexate (mtx); Methotrexate + biologic administration; Methotrexate + infliximab; Methotrexate + methylprednisolone; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate - amneal; Methotrexate - dava; Methotrexate - delay; Methotrexate - etanercept - prednisolone arm; Methotrexate - immediate; Methotrexate 2.5 mg tablets; Methotrexate 2.5mg tablets; Methotrexate 2.5mg tablets bp; Methotrexate 50mg/ml solution for injection, pre-filled syringe; Methotrexate as methotrexate disodium; Methotrexate capsules; Methotrexate disodium; Methotrexate pfizer 2,5 mg tabletter; Methotrexate placebo; Methotrexate plus enbrel or enbrel alone; Methotrexate plus erb-041 for 12 weeks; Methotrexate plus sulfasalazine; Methotrexate pre-filled pen; Methotrexate prefilled pen; Methotrexate prefilled syringe; Methotrexate sodium; Methotrexate sodium 2.5mg tablets; Methotrexate sodium tablets 2.5 mg; Methotrexate(mtx); Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol.; Methotrexate(necessary); Methotrexate*100cpr 2,5mg; Methotrexate, leucovorin and bms-986142; Methotrexate,adalimumab; Methotrexate-lachema; Methotrexate-sulfasalazine-hydroxychloroquine; Methotrexate® 2.5 mg tablets; Mp-435(dose1) + methotrexate; Oral methotrexate; Phase 1: methotrexate; Response to anakinra associated with methotrexate; Response to infliximab associated with methotrexate; Stable weekly dose of methotrexate; Tacrolimus with methotrexate; Tasocitinib plus methotrexate; Tocilizumab + methotrexate(mtx); Tocilizumab+methotrexate(mtx); Tofacitinib with methotrexate; Tofacitinib without methotrexate; Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Methotrexate and folic acid; Methotrexate lachema 5inj. sol; Etanercept, methotrexate, prednisolone; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Azathioprine or methotrexate; Early immunosuppressants (azathioprine, methotrexate); Methotrexate bellon; Methotrexate bellon 25mg/ml; Clobetasol propionate + methotrexate; Treatment with systemic therapy (methotrexate); Cyclosporin, methotrexate (gvhd prophylaxis);   D00142
 D02115 
 2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331
 123   Methylene blue  2件: Methylene blue; Methylene blue 25mg tablets;   D02312
 D10537 
 -   -   2件:
97,
127
 124   Methylprednisolone  29件: Methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methylprednisolone (drug); Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Methylprednisolone (or other glucocorticoid); Prednisone (and methylprednisolone); Infliximab, methylprednisolone, methotrexate; Methotrexate + methylprednisolone; Administration of rituximab and methylprednisolone; Methylprednisolone (mp); Corticosteroid treatment (methylprednisolone or prednisolone); Methylprednisolone or prednisolone; Methylprednisolone (mp) or prednisone (pred); Methylprednisolone mylan générique; Methylprednisolone pulse; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone or budesonide; Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Intravenous methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9;   D00407
 D00751
 D00979
 D05000
 D05001
 D05002 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296
 125   Methylprednisolone hemisuccinate  1件: Methylprednisolone hemisuccinate;   D05000   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
13,
97
 126   Metronidazole  6件: Metronidazole; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); 10% metronidazole ointment; Azithromycin + metronidazole; Amoxicillin, metronidazole and tetracycline; Metronidazole capsule 50 mg;   D00409
 D05016
 D05017 
 -   -   8件:
46,
51,
63,
94,
95,
96,
97,
291
 127   Midazolam  6件: Midazolam; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; S-ketamine & midazolam; Midazolam 2 mg; Midazolam 3 mg;   D00550
 D00696
 D05028 
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   10件:
2,
3,
6,
13,
46,
70,
96,
97,
231,
298
 128   Mirikizumab  1件: Mirikizumab;   D11123   1件: IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   2件:
96,
97
 129   Mongersen  1件: Mongersen;   D10956   -   -   2件:
96,
97
 130   Muromonab  2件: Muromonab; Muromonab-cd3;   D05092   3件: CD3D, CD3E, CD3G   3件: T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   3件:
60,
96,
97
 131   Myrrh  2件: Myrrh; Myrrhinil-intest®;   D08948   -   -   1件:
97
 132   Naltrexone  5件: Naltrexone; Naltrexone hydrochloride; 4.5 mg naltrexone; Low dose naltrexone; Naltrexone-hcl;   D02095
 D05113 
 3件: OPRD1, OPRK1, OPRM1   2件: Morphine addiction, Neuroactive ligand-receptor interaction   11件:
6,
10,
13,
40,
41,
42,
43,
44,
45,
96,
97
 133   Neomycin  1件: Neomycin;   D08260   -   -   4件:
96,
97,
296,
299
 134   Niclosamide  1件: Niclosamide;   D00436   -   -   2件:
46,
97
 135   Nitazoxanide  3件: Nitazoxanide; Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet; Nitazoxanide 500mg oral tablet;   D02486   -   -   2件:
96,
97
 136   Nivolumab  1件: Nivolumab;   D10316   1件: PDCD1   3件: Cell adhesion molecules (CAMs), PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway   10件:
13,
26,
41,
46,
49,
50,
51,
53,
96,
97
 137   ORE-1001  0件:   -   -   -   1件:
97
 138   Omeprazole  19件: Clartihromycin, amoxicillin, and omeprazole; Esomeprazole; Omeprazole; Dimebon + omeprazole; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Diclofenac + omeprazole; Esomeprazole 20 mg; Naproxen 500 mg tablets (pn 200 minus omeprazole); Pn 200 tablets (500 mg naproxen and 20 mg omeprazole); Omeprazole 20mg; Omeprazole (uk licensed generic product); Omeprazole 20 mg; Omeprazole 40 mg; Rifaximin+omeprazole+miralax; Omeprazole 20mg bid; Omeprazole magnesium; Omeprazole rectally 1mg/kg; Nexium (esomeprazole magnesium); Omeprazole 40mg capsule;   D00455
 D01207
 D05259
 D05261 
 2件: ATP4A, ATP4B   2件: Collecting duct acid secretion, Gastric acid secretion   15件:
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299
 139   Oxygen  10件: Oxygen; Oxygen 40 %; Nitric oxide plus oxygen; Oxygen supplementation; Continuous oxygen; Medical air vs oxygen; Maternal hyperoxygenation; Medical grade oxygen; Perfluorinated gas/oxygen mixture; Helium / oxygen mixed gas inhalation therapy;   D00003   -   -   18件:
5,
6,
17,
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
211,
226,
299,
330
 140   Ozanimod  5件: Ozanimod; Ozanimod 0.5 mg; Ozanimod 1 mg; Ozanimod hydrochloride; Rpc1063 (equivalent to ozanimod hcl);   D10968   5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5   2件: Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   3件:
13,
96,
97
 141   PF-06651600  1件: Pf-06651600;   -   -   -   3件:
46,
96,
97
 142   PF-06700841  4件: Pf-06700841; Pf-06700841 15 mg; Pf-06700841 30 mg; Pf-06700841 45 mg;   -   -   -   3件:
49,
96,
97
 143   Palmitoleic Acid  1件: Palmitoleic acid;   -   -   -   1件:
97
 144   Pancrelipase  9件: Pancrelipase; Pancrelipase delayed release capsule; Pancrelipase/pancreas powder; Viokase 16 (pancrelipase) + nexium; Pancrecarb® (pancrelipase); Pancrelipase amylase; Pancrelipase delayed release; Pancrelipase microtablets; Pancrelipase with bicarbonate;   D05349   -   -   4件:
96,
97,
298,
299
 145   Pancrelipase amylase  1件: Pancrelipase amylase;   -   -   -   4件:
96,
97,
298,
299
 146   Pancrelipase lipase  0件:   -   -   -   4件:
96,
97,
298,
299
 147   Pancrelipase protease  0件:   -   -   -   4件:
96,
97,
298,
299
 148   Parnaparin  2件: Parnaparin; Parnaparin sodium;   D07510   1件: SERPINC1   1件: Complement and coagulation cascades   1件:
97
 149   Phosphate ion  0件:   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299
 150   Picosulfuric acid  0件:   -   -   -   2件:
97,
291
 151   Plantago seed  0件:   D05525   -   -   1件:
97
 152   Polaprezinc  1件: Polaprezinc;   D01611   -   -   2件:
96,
97
 153   Polyethylene glycol  3件: Polyethylene glycol; Polyethylene glycol 3350; 2l polyethylene glycol/ascorbic acid;   D03370   -   -   2件:
96,
97
 154   Pomegranate  1件: Pomegranate;   -   -   -   2件:
96,
97
 155   Prednisolone  74件: Prednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methyloprednisolone; Methylprednisolone; Methylprednisolone (drug); Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Peg-liposomal prednisolone sodium phosphate; Prednisolone sodium phosphate; Prednisone/prednisolone; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Intravenous methyl prednisolone; Methyl prednisolone; Methylprednisolone (or other glucocorticoid); Prednisone (and methylprednisolone); Prednisone, methylprednisolone,cyclophosphamides; Infliximab, methylprednisolone, methotrexate; Long-circulating liposomal prednisolone; Methotrexate + methylprednisolone; Methotrexate - etanercept - prednisolone arm; Overencapsulated prednisolone tablets; Paroxetine & prednisolone; Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp; Prednisolone & dipyridamole; Prednisolone 20 mg; Prednisolone 40 mg; Prednisolone 5 mg; Prednisolone tablets bp; Prednisolone tablets usp 5 mg; Prednisolone-dipyridamole; Sulphasalazine + hydroxychloroquine or prednisolone; Trexan+salazopyrin+oxiklorin+prednisolone; Trexan+salazopyrin+oxiklorin+prednisolone + infliximab; Z102 (prednisolone and dipyridamole).; Corticosteroids (prednisone or prednisolone); Oral prednisolone; Administration of rituximab and methylprednisolone; Prednisolone and taper; Etanercept, methotrexate, prednisolone; Methylprednisolone (mp); Prednisolone + mabthera; Corticosteroid treatment (methylprednisolone or prednisolone); Methylprednisolone or prednisolone; Methylprednisolone (mp) or prednisone (pred); Methylprednisolone mylan générique; Methylprednisolone pulse; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Prednisone or prednisolone; Azd4017 and prednisolone; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Prednisolone 1mg tablets; Prednisolone 5mg tablet; Glucocorticoid (prednisone or prednisolone); Low dose prednisolone; Medium dose prednisolone; Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Corticosteroid (prednisolone); Prednisolone sodium succinate; Methylprednisolone or budesonide; Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Prednisolone sodium metasulphobenzoate; Prednisolone tablets b.p. 5mg; Intravenous methylprednisolone; Pyridoxine plus prednisolone; Soluble prednisolone tablets; Intravenous (i.v.) methylprednisolone 1000 mg, total 9; Prednisolone acetate; Prednisolone and chlorambucil; Prednisolone and mycophenolate mofetil;   D00472
 D00980
 D00981
 D00982
 D01239
 D01998
 D02156
 D03301 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300
 156   Prednisone  59件: Prednisone; Prednisone - azathioprine; Prednisone alone; Granulocyte-colony stimulating factor (g-csf) and prednisone; Prednisone/prednisolone; Prednisone acetate; Prednisone, cyclophosphamide; Over encapsulated prednisone; Prednisone and ustekinumab treatment; Prednisone capsules; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Prednisone (and methylprednisolone); 0 mg prednisone; 5 mg prednisone; Methylprednisone; Prednisone 15 mg; Prednisone 5 mg; Prednisone 7.5 mg; Rayos (delayed-release prednisone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide-prednisone-azathioprine; Oral prednisone 5mg; Prednisone discontinuation; Chinese herb prescription granule plus prednisone; Enalapril valsartan methylprednisone; Hormone (prednisone); Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Mycophenolate mofetil plus lower dose of prednisone; Prednisone + inhibace/cozaar; Prednisone and cyclophosphamide; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Glucocorticoid (prednisone or prednisolone); Hydroxychloroquine + prednisone; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; 5-aminosalicylic acid(5-asa) and/or prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Prednisone 0,5 mg/kg orally on alternate days; Prednisone, fk506, mmf; Tacrolimus combined with prednisone; Prednisone acetate tablets; Oral prednisone; Sotatercept with prednisone boost; Prednisone and mycophenolate mofetil; Thalidomide, cyclophosphamide and prednisone;   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   44件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331
 157   Proline  4件: Cis-4-hydroxy-l-proline; Proline; D-proline; Lysine-d-proline-threonine;   D00035   -   -   2件:
94,
97
 158   Raspberry  2件: Freeze-dried black raspberry powder; Raspberry;   -   -   -   1件:
97
 159   Rebamipide  1件: Rebamipide;   D01121   -   -   4件:
46,
53,
97,
271
 160   Riboflavin  4件: Riboflavin; Riboflavin sodium phosphate injection; Riboflavin supplementation; Cofactor supplementation (thiamine, riboflavin, l-carnitine);   D00050
 D01622
 D01913 
 -   -   9件:
13,
38,
46,
49,
96,
97,
162,
168,
265
 161   Rice  1件: Rice;   -   -   -   1件:
97
 162   Rifaximin  10件: Rifaximin; Rifaximin 550 mg; Rifaximin delayed release (dr); Rifaximin delayed release 400 mg film coated tablet; Rifaximin delayed release tablets; Rifaximin eir; Rifaximin+omeprazole+miralax; Rifaximin-eir; Rifaximina; Rifaximin oral tablet;   D02554   -   -   7件:
6,
65,
94,
96,
97,
99,
296
 163   Risankizumab  4件: Risankizumab; Risankizumab iv; Risankizumab sc; Risankizumab (genetical recombination);   D11052   1件: IL23A   3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Th17 cell differentiation   4件:
37,
96,
97,
271
 164   Rituximab  52件: Rituximab; Rituximab (rituxan); Mabthera (rituximab); Mabthera or biosimilar rituximab product; Rituximab infusion; Rituximab it; Rituximab iv; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Rituximab (mabthera® or rituxan®).; Rituximab and cyclophosphamide iv; Rituximab (arm a); Rituximab (arm b); Abatacept, rituximab or tocilizumab; Abp 798 - biosimilar to rituximab; Gp2013 - a proposed biosimilar rituximab; Idec-c2b8 (rituximab); Mabthera® (rituximab); Originator rituximab - rituxan ® or mabthera ®; Rituxan (inn: rituximab), brand name in the united states; Rituxan® (rituximab); Rituximab - mabthera; Rituximab [mabthera/rituxan]; Rituximab [mabthera]; Rituximab mabthera; Rituximab, mtx, folic acid; Rituximab, observational study amon patients with active ra; Rituximab-eu+ rituximab-pfizer x 2 courses; Rituximab-pfizer (pf-05280586) x 3 courses; Rituximab-us + rituximab-pfizer x 2 courses; Sait101 (proposed rituximab biosimilar); Individualized dose of rituximab; Rituxan (rituximab); Standard dose of rituximab; Administration of rituximab and methylprednisolone; Rituximab (anti-cd20); Alemtuzumab and rituximab; Bendamustine, rituximab; Mabthera or biosimilar rituximab; Rituximab (mabthera®); Alemtuzumab, rituximab; Dexamethasone and rituximab; Rhtpo in combination with rituximab; Immunosuppressive treatment (eg, rituximab); Rituximab (rtx) and azathioprine (aza); Intravenous rituximab; Combined plasma exchange (pex), rituximab, and corticosteroids; The standard steroid treatment, plasma exchange and rituximab; Rituximab 1g iv; Rituximab combined with omalizumab; Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab); Rituximab/ mabthera; Rituximab or rituximab hyaluronidase human;   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331
 165   Rosiglitazone  6件: Rosiglitazone; Rosiglitazone extended release tablets; Rosiglitazone maleate; Rosiglitazone xr; Rosiglitazone (avandia); Recombinant human growth hormone + rosiglitazone;   D00596
 D08491 
 1件: PPARG   2件: AMPK signaling pathway, PPAR signaling pathway   5件:
46,
75,
97,
222,
265
 166   SC12267  2件: Sc12267; Sc12267 (4sc-101);   -   -   -   3件:
46,
96,
97
 167   SRT-2104  0件:   -   -   -   1件:
97
 168   Salicylic acid  8件: -aminosalicylic acid; 5-amino salicylic acid; 5-amino salicylic acid (5-asa); 5-aminosalicylic acid; 5-aminosalicylic acid (5-asa); 5-aminosalicylic acid(5-asa) and/or prednisone; Aminosalicylic acid; Salicylic acid;   D00097   -   -   1件:
97
 169   Sodium chloride  14件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); Sodium chloride; Sodium chloride solution; Isotonic sodium chloride solution; 0.9% sodium chloride injection; Physiological serum (sodium chloride); Sodium chloride solvent; Sodium chloride solution 0.9%; 0.9% w/v sodium chloride solution; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 6%; Sodium pyruvate in 0.9% sodium chloride solution;   D02056   -   -   19件:
6,
11,
13,
14,
17,
34,
46,
51,
53,
67,
78,
86,
97,
168,
193,
227,
228,
288,
299
 170   Sotrastaurin  2件: Sotrastaurin; Sotrastaurin (inn) acetate;   D09671   4件: PRKCD, PRKCE, PRKCH, PRKCQ   2件: Inflammatory mediator regulation of TRP channels, T cell receptor signaling pathway   1件:
97
 171   Soybean  2件: Soybean; Soybean phosphatidylcholine;   -   -   -   1件:
97
 172   Sucrose  2件: Iron sucrose; Sucrose;   D00025   -   -   3件:
62,
96,
97
 173   TOP-1288  0件:   -   -   -   1件:
97
 174   Tacrolimus  13件: Tacrolimus; Tacrolimus capsule; Interferon beta-1b and tacrolimus; Non-mtx dmards (e.g. sulfasalazine, leflunomide, bucillamine, tacrolimus, or mizoribin); Tacrolimus (prograf®); Tacrolimus with methotrexate; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Lcp-tacro (tacrolimus); Rectal tacrolimus; Tacrolimus capsules; Tacrolimus combined with prednisone; Tacrolimus and mmf; Tacrolimus prolonged-release hard capsules;   D00107
 D08556 
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   30件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
86,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299
 175   Telotristat  2件: Telotristat; Telotristat etiprate;   D09973   2件: TPH1, TPH2   2件: Serotonergic synapse, Tryptophan metabolism   1件:
97
 176   Terbinafine  1件: Terbinafine;   D02219
 D02375 
 -   -   1件:
97
 177   Tetomilast  2件: Opc-6535(tetomilast); Tetomilast;   -   -   -   2件:
96,
97
 178   Tetracycline  4件: Tetracycline; Tetracycline - statin - antimycotic; Amoxicillin and tetracycline; Amoxicillin, metronidazole and tetracycline;   D00201   -   -   5件:
13,
36,
46,
53,
97
 179   Thalidomide  9件: Thalidomide; Thalidomide (drug); Fpf 300 (thalidomide); Melphalan, thalidomide and dexamethasone; Thalidomide pharmion; Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule; Thalidomide 100mg; Thalidomide 150mg; Thalidomide, cyclophosphamide and prednisone;   D00754   1件: TNF   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, TNF signaling pathway   18件:
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331
 180   Tofacitinib  23件: Chong kun dang tofacitinib tablet; Cp-690,550 (tofacitinib); Tofacitinib; Tofacitinib (xeljanz); Tofacitinib 5 mg; Tofacitinib 5 mg [xeljanz]; Tofacitinib 5mg po bid; Tofacitinib citrate; Tofacitinib citrate (clinical trial image); Tofacitinib citrate (commercial image); Tofacitinib citrate cp-690550; Tofacitinib with methotrexate; Tofacitinib without methotrexate; Tofacitinib/baricitinib; Tofacitinib 5 mg twice daily; Tofacitinib 5mg [xeljanz] 1 year open-label extension; Tofacitinib 5mg oral tablet [xeljanz] 16 week trial; 15n2-tofacitinib; Tofacitinib citrate (proposed commercial formulation – debossed); In double-blind phase: treatment with tofacitinib; In open-label phase: treatment with tofacitinib; Tofacitinib 10 mg; Tofacitinib 2 mg;   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   9件:
46,
49,
50,
51,
84,
96,
97,
107,
271
 181   Topramezone  0件:   -   -   -   7件:
6,
13,
46,
50,
96,
97,
299
 182   Tralokinumab  4件: Tralokinumab; Tralokinumab cohort 1; Tralokinumab cohort 2; Tralokinumab is a human recombinant monoclonal antibody (mab) of the subclass that specifically binds human il-13, blocking interactions with the il-13 receptor;   D09979   1件: IL13   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   2件:
85,
97
 183   Triamcinolone  10件: Triamcinolone; Triamcinolone acetonide; Triamcinolone hexacetonid (lederspan); Triamcinolone hexacetonide; Triamcinolone hexacetonide (lederspan); Triamcinolone acetonide and normal saline solution; Bladder instillation with triamcinolone acetonide; Bladder instillation without triamcinolone acetonide; Bupivacaine & triamcinolone acetonide; Intra plexus triamcinolone and bupivicaine injection;   D00385
 D00983
 D00984
 D00985
 D06216 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   18件:
6,
10,
13,
35,
40,
41,
42,
43,
44,
45,
46,